SURGICAL INNOVATIONS GROUP PLC

Board/Management Information • May 8, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1841E

Surgical Innovations Group PLC

08 May 2013

Surgical Innovations Group plc

("SI" or the "Company")

Senior Appointment of President of US Sales and Operations

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Rick Barnett as President of US Sales and Operations with immediate effect.

Rick joins the Company from Integrated Medical Systems Inc where he worked in the Management and Consulting Division. He managed a division that provided on-site clinical support for minimally invasive procedures. Rick previously served as the US Senior Director for Intuitive Surgical and between 1998 - 2008 as National Director for Endoscopic Sales within the Stryker Corporation.

An important focus for SI's strategy moving forward is to drive the SI Branded products through investment in Sales and Marketing especially in the US where it is ideally placed to leverage its growing position in this market. Rick will have responsibility for managing the various US sales channels SI have previously established and will aim to grow the US business utilising his vast experience in the endoscopic sector. The US remains SI's largest market opportunity, with 28% of overall revenues generated from the US in 2012.

Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "Rick Barnett is an outstanding appointment for SI as we continue to develop our presence in the US market. He brings with him extensive knowledge of the endoscopic industry and a proven track record in developing new business and sales opportunities that will enable him to accelerate the growth of the SI business   in the United States."

- ENDS -

Enquiries:

Surgical Innovations Group plc		www.sigroupplc.com
Doug Liversidge, Non-Executive Chairman		Tel: +44 (0) 113 230 7597
Graham Bowland, Chief Executive Officer		graham.bowland@surginno.co.uk
Panmure Gordon (Nominated Advisor & Broker)		www.panmure.com
Freddy Crossley / Fred Walsh (Corporate Finance)		Tel: +44 (0) 20 7886 2500
Adam Pollock/ Victoria Boxall (Corporate Broking)
Walbrook PR Ltd	Tel: +44 (0) 20 7933 8780
Paul McManus	Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com
Lianne Cawthorne	Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
OEM and IP	The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigrouplplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCARMBTMBBMTJJ